Open access
Sep 2026
CRISPR-Mediated Epigenetic Reprogramming Attenuates Inflammatory Cell Injury Through Targeted Transcriptional Modulation: An Experimental in Vitro and in Vivo Study
The concordant in vitro and in vivo findings identify targeted epigenetic reprogramming as a potential strategy for controlling pathological inflammation without permanent alteration of genomic DNA.
Hiroshi Takamura, Yuki Nakamura, Rina Fujimoto et al.
· Advanced Journal of Biomedic... · 0 citations